134 related articles for article (PubMed ID: 37976763)
1. Comments on "Current status and quality of radiomic studies for predicting KRAS mutations in colorectal cancer patients: A systematic review and meta-analysis".
Fusco R; Granata V
Eur J Radiol; 2023 Dec; 169():111192. PubMed ID: 37976763
[TBL] [Abstract][Full Text] [Related]
2. Current status and quality of radiomic studies for predicting KRAS mutations in colorectal cancer patients: A systematic review and meta‑analysis.
Jia LL; Zhao JX; Zhao LP; Tian JH; Huang G
Eur J Radiol; 2023 Jan; 158():110640. PubMed ID: 36525703
[TBL] [Abstract][Full Text] [Related]
3. Response to letter by Fusco Roberta & Vincenza Granata-Re: Comments on "Current status and quality of radiomic studies for predicting KRAS mutations in colorectal cancer patients: A systematic review and meta‑analysis".
Jia LL; Lei J
Eur J Radiol; 2024 Jun; 175():111195. PubMed ID: 38669754
[No Abstract] [Full Text] [Related]
4. Can CT-based radiomics signature predict KRAS/NRAS/BRAF mutations in colorectal cancer?
Yang L; Dong D; Fang M; Zhu Y; Zang Y; Liu Z; Zhang H; Ying J; Zhao X; Tian J
Eur Radiol; 2018 May; 28(5):2058-2067. PubMed ID: 29335867
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive KRAS mutation estimation in colorectal cancer using a deep learning method based on CT imaging.
He K; Liu X; Li M; Li X; Yang H; Zhang H
BMC Med Imaging; 2020 Jun; 20(1):59. PubMed ID: 32487083
[TBL] [Abstract][Full Text] [Related]
6. Construction of prediction model for KRAS mutation status of colorectal cancer based on CT radiomics.
Cao Y; Zhang J; Huang L; Zhao Z; Zhang G; Ren J; Li H; Zhang H; Guo B; Wang Z; Xing Y; Zhou J
Jpn J Radiol; 2023 Nov; 41(11):1236-1246. PubMed ID: 37311935
[TBL] [Abstract][Full Text] [Related]
7. Effect of KRAS and BRAF Mutations on Survival of Metastatic Colorectal Cancer After Liver Resection: A Systematic Review and Meta-Analysis.
Tosi F; Magni E; Amatu A; Mauri G; Bencardino K; Truini M; Veronese S; De Carlis L; Ferrari G; Nichelatti M; Sartore-Bianchi A; Siena S
Clin Colorectal Cancer; 2017 Sep; 16(3):e153-e163. PubMed ID: 28216246
[TBL] [Abstract][Full Text] [Related]
8. The current understanding on the impact of KRAS on colorectal cancer.
Meng M; Zhong K; Jiang T; Liu Z; Kwan HY; Su T
Biomed Pharmacother; 2021 Aug; 140():111717. PubMed ID: 34044280
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of F-18 FDG PET/CT for prediction of KRAS mutation in colorectal cancer patients: a systematic review and meta-analysis.
Kim SJ; Pak K; Kim K
Abdom Radiol (NY); 2019 May; 44(5):1703-1711. PubMed ID: 30603881
[TBL] [Abstract][Full Text] [Related]
10. CT texture analysis for the prediction of KRAS mutation status in colorectal cancer via a machine learning approach.
Taguchi N; Oda S; Yokota Y; Yamamura S; Imuta M; Tsuchigame T; Nagayama Y; Kidoh M; Nakaura T; Shiraishi S; Funama Y; Shinriki S; Miyamoto Y; Baba H; Yamashita Y
Eur J Radiol; 2019 Sep; 118():38-43. PubMed ID: 31439256
[TBL] [Abstract][Full Text] [Related]
11. Preoperative prediction of perineural invasion and KRAS mutation in colon cancer using machine learning.
Li Y; Eresen A; Shangguan J; Yang J; Benson AB; Yaghmai V; Zhang Z
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3165-3174. PubMed ID: 32779023
[TBL] [Abstract][Full Text] [Related]
12. Relationship between KRAS mutations and dual time point
Mao W; Zhou J; Zhang H; Qiu L; Tan H; Hu Y; Shi H
Abdom Radiol (NY); 2019 Jun; 44(6):2059-2066. PubMed ID: 30143816
[TBL] [Abstract][Full Text] [Related]
13. KRAS mutation testing of tumours in adults with metastatic colorectal cancer: a systematic review and cost-effectiveness analysis.
Westwood M; van Asselt T; Ramaekers B; Whiting P; Joore M; Armstrong N; Noake C; Ross J; Severens J; Kleijnen J
Health Technol Assess; 2014 Oct; 18(62):1-132. PubMed ID: 25314637
[TBL] [Abstract][Full Text] [Related]
14. Not All Kirsten Rat Sarcoma Viral Oncogene Homolog Mutations Predict Poor Survival in Patients With Unresectable Colorectal Liver Metastasis.
Lin Z; Liu Y; Cai S; Yang C; Zhou L; Li W
Technol Cancer Res Treat; 2021; 20():15330338211039131. PubMed ID: 34669528
[No Abstract] [Full Text] [Related]
15. Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer.
Chan DLH; Segelov E; Wong RS; Smith A; Herbertson RA; Li BT; Tebbutt N; Price T; Pavlakis N
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007047. PubMed ID: 28654140
[TBL] [Abstract][Full Text] [Related]
16. Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms.
Shiri I; Maleki H; Hajianfar G; Abdollahi H; Ashrafinia S; Hatt M; Zaidi H; Oveisi M; Rahmim A
Mol Imaging Biol; 2020 Aug; 22(4):1132-1148. PubMed ID: 32185618
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional imaging signature for V-KI-RAS2 Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations in colorectal cancer.
Miles KA; Ganeshan B; Rodriguez-Justo M; Goh VJ; Ziauddin Z; Engledow A; Meagher M; Endozo R; Taylor SA; Halligan S; Ell PJ; Groves AM
J Nucl Med; 2014 Mar; 55(3):386-91. PubMed ID: 24516257
[TBL] [Abstract][Full Text] [Related]
18. KRAS p.G13D mutation and codon 12 mutations are not created equal in predicting clinical outcomes of cetuximab in metastatic colorectal cancer: a systematic review and meta-analysis.
Mao C; Huang YF; Yang ZY; Zheng DY; Chen JZ; Tang JL
Cancer; 2013 Feb; 119(4):714-21. PubMed ID: 22972628
[TBL] [Abstract][Full Text] [Related]
19. Predicting cetuximab accumulation in KRAS wild-type and KRAS mutant colorectal cancer using 64Cu-labeled cetuximab positron emission tomography.
Achmad A; Hanaoka H; Yoshioka H; Yamamoto S; Tominaga H; Araki T; Ohshima Y; Oriuchi N; Endo K
Cancer Sci; 2012 Mar; 103(3):600-5. PubMed ID: 22126621
[TBL] [Abstract][Full Text] [Related]
20. Impact of feature harmonization on radiogenomics analysis: Prediction of EGFR and KRAS mutations from non-small cell lung cancer PET/CT images.
Shiri I; Amini M; Nazari M; Hajianfar G; Haddadi Avval A; Abdollahi H; Oveisi M; Arabi H; Rahmim A; Zaidi H
Comput Biol Med; 2022 Mar; 142():105230. PubMed ID: 35051856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]